Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft
Vandekerckhove, B.A.; Datema, G.; Koning, F.; Goulmy, E.; Persijn, G.G.; van Rood, J.J.; Claas, F.H.; de Vries, J.E.
Transplantation Proceedings 22(4): 1871-1872
1990
ISSN/ISBN: 0041-1345 PMID: 2389465 Document Number: 348732
Document emailed within 1 workday
Related Documents
van Twuyver, E.; de Hoop, J.; ten Berge, R.J.; Wilmink, J.M.; Lems, S.P.; van de Berg, A.P.; Slooff, M.J.; de Waal, L.P. 1996: Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world Transplantation 61(9): 1392-1397Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Eberlein, T.J.; Rosenstein, M.; Spiess, P.J.; Rosenberg, S.A. 1982: Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma Journal of the National Cancer Institute 69(1): 109-116
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Christiaans, M.H.; van Hooff, J.P.; Nieman, F.; van den Berg-Loonen, E.M. 1999: HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome Transplantation 67(7): 1029-1035
Hayamizu, K.; Zeng, D.; Huie, P.; Garcia-Ojeda, M.E.; Bloch, D.A.; Fong, L.; Engleman, E.G.; Sibley, R.K.; Strober, S. 1998: Donor blood monocytes but not T or B cells facilitate long-term allograft survival after total lymphoid irradiation Transplantation 66(5): 585-593
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Pellegrino, M.G.; Bluth, M.H.; Smith-Norowitz, T.; Fikrig, S.; Volsky, D.J.; Moallem, H.; Auci, D.L.; Nowakowski, M.; Durkin, H.G. 2002: HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro Aids Research and Human Retroviruses 18(5): 363-372
Gjertson, D.W. 1991: Survival trends in long-term first cadaver-donor kidney transplants Clinical Transplants 1991: 225-235
Ol'khovskaia, I.G.; Frank, G.A. 1985: All-Union registry data on long-term surviving patients with small cell lung cancer Voprosy Onkologii 31(10): 15-18
Orlowski, T.; Smogorzewski, M.; Kurkus, J. 1985: Niridazole as an adjunct to "conventional" immunosuppression in kidney allograft transplantation. Long-term follow up Archivum Immunologiae et Therapiae Experimentalis 33(6): 797-801
Kusama, M.; Kimura, K.; Suzuki, K.; Fukaya, Y.; Saitoh, S.; Eiraku, H.; Kawahara, S.; Ueno, M.; Kawaguchi, M. 1989: A long-surviving case of gastric cancer with peritoneal metastasis (P3) responding to short-term high-dose chemotherapy and long-term immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(10): 3453-3456
Ghorbani, R.P.; Shokouh-Amiri, H.; Gaber, L.W. 1996: Intragraft angiotropic large-cell lymphoma of T cell-type in a long-term renal allograft recipient Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(6): 671-676
Yoon, Y.S.; Bang, B.K.; Jin, D.C.; Ahn, S.J.; Yoon, J.Y.; Park, Y.H.; Koh, Y.B. 1992: Factors influencing long-term outcome of living-donor kidney transplantation in the cyclosporine era Clinical Transplants 1992: 257-266
Lantz, O.; Alard, P.; Ben Aribia, H.; Fries, D.; Senik, A.; Charpentier, B. 1989: Suppressive phenomena and absence of clonal deletion evidenced by limiting dilution analysis (LDA) of donor-specific IL2 secreting cells (IL2 SC) and cytotoxic precursors (CTLp) Transplantation Proceedings 21(1 Part 1): 367-368
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Hernández-Infante, E.; García-Martínez, C.; Beltrán-de-la-Luz, S.; Reyes-Acevedo, R.; Romo-Franco, L.; Delgadillo-Castañeda, R.; Orozco-Loza, I.; Chew-Wong, A. 2010: Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(5): 398-405
Maruta, A.; Fukawa, H.; Kanamori, H.; Harano, H.; Noguchi, T.; Kodama, F.; Kase, N.; Matsuzaki, M.; Miyashita, H.; Motomura, S. 1991: Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patient Bone Marrow Transplantation 7(5): 397-400
Finn, O.J.; Miceli, M.C. 1989: Effector T-cell repertoire selection in human allograft rejection Transplantation Proceedings 21(1 Pt 1): 346-348